ET-1 plasma levels, choroidal thickness and multifocal electroretinogram in retinitis pigmentosa

Life Sciences

Volumn 118, Issue 2, 2014, Pages 386-390

  Finzi, Alessandro ^a   Cellini, Mauro ^a   Strobbe, Ernesto ^a   Campos, Emilio C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Choroidal thickness; ET 1; Multifocal ERG; Retinitis pigmentosa

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CHOROIDAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; PHOTORECEPTOR; RETINITIS PIGMENTOSA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL FIELD; BLOOD; CASE CONTROL STUDY; CHOROID; DEMOGRAPHY; ELECTRORETINOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY;

ADULT; CASE-CONTROL STUDIES; CHOROID; DEMOGRAPHY; ELECTRORETINOGRAPHY; ENDOTHELIN-1; FEMALE; HUMANS; MALE; RETINITIS PIGMENTOSA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84942612308     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.04.004     Document Type: Article

References (32)

1. Akyol, N., Kükner, S., Celiker, U., Koyu, H., Lüleci, C., Decreased retinal blood flow in retinitis pigmentosa. Can J Ophthalmol 30:1 (1995), 28–32.
2. Cellini, M., Lodi, R., Possati, G.L., Sbrocca, M., Pelle, D., Giubilei, N., Color Doppler ultrasonography in retinitis pigmentosa. Preliminary study. J Fr Ophtalmol 20:9 (1997), 659–663.
3. Cellini, M., Santiago, L., Versura, P., Caramazza, R., Plasma levels of endothelin-1 in retinitis pigmentosa. Ophthalmologica 216:4 (2002), 265–268.
4. Cellini, M., Strobbe, E., Gizzi, C., Campos, E.C., ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol 88:6 (2010), 630–635.
5. Dhoot, D.S., Huo, S., Yuan, A., Xu, D., Srivistava, S., Ehlers, J.P., et al. Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomography. Br J Ophthalmol 97:1 (2013), 66–69.
6. Falsini, B., Anselmi, G.M., Marangoni, D., D'Esposito, F., Fadda, A., Di Renzo, A., et al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci 52:2 (2011), 1064–1069.
7. Flammer, J., Konieczka, K., Flammer, A.J., The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J, 4, 2013, 14, 10.1186/1878-5085-4-14.
8. Grunwald, J.E., Maguire, A.M., Dupont, J., Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol 122:4 (1996), 502–508.
9. Hamel, C., Retinitis pigmentosa. Orphanet J Rare Dis, 1, 2006, 40.
10. Heckenlively, J.R., Yoser, S.L., Friedman, L.H., Oversier, J.J., Clinical findings and common symptoms in retinitis pigmentosa. Am J Ophthalmol 105 (1988), 504–511.
11. Hood, D.C., Bach, M., Brigell, M., Keating, D., Kondo, M., Lyons, J.S., et al. International Society for Clinical Electrophysiology of Vision. ISCEV Standard for Clinical Multifocal Electroretinography (mfERG) (2011 edition). Doc Ophthalmol 124:1 (2012), 1–13.
12. Kobayashi, T., Oku, H., Fukuhara, M., Kojima, S., Komori, A., Ichikawa, M., et al. Endothelin-1 enhances glutamate-induced retinal cell death, possibly through ETA receptors. Invest Ophthalmol Vis Sci 46:12 (2005), 4684–4690.
13. Konieczka, K., Flammer, A.J., Todorova, M., Meyer, P., Flammer, J., Retinitis pigmentosa and ocular blood flow. EPMA J, 3(1), 2012, 17.
14. Langham, M.E., Kramer, T., Decreased choroidal blood flow associated with retinitis pigmentosa. Eye (Lond) 4 (1990), 374–381.
15. Li, Z.Y., Possin, D.E., Milam, A.H., Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology 102:5 (1995), 805–816.
16. MacCumber, M.W., Jampel, H.D., Snyder, S.H., Ocular effects of the endothelins. Abundant peptides in the eye. Arch Ophthalmol 109:5 (1991), 705–709.
17. Marmor, M.F., Fulton, A.B.., Holder, G.E., Miyake, Y., Brigell, M., Bach, M., International Society for Clinical Electrophysiology of Vision. ISCEV Standard for Full-field Clinical Electroretinography (2008 update). Doc Ophthalmol 118:1 (2009), 69–77.
18. Martínez-Fernández de la Cámara, C., Salom, D., Sequedo, M.D., Hervás, D., Marín-Lambíes, C., Aller, E., et al. Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One, 8, 2013, e74223, 10.1371/journal.pone.0074223 [Sep12, eCollection 2013].
19. Masaki, T., Kimura, S., Yanagisawa, M., Goto, K., Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84:4 (1991), 1457–1468.
20. Miyake, Y., Focal macular electroretinography. Nagoya J Med Sci 61:3–4 (1998), 79–84.
21. Ohguro, H., Mashima, Y., Nakazawa, M., Low levels of plasma endothelin-1 in patients with retinitis pigmentosa. Clin Ophthalmol 4 (2010), 569–573.
22. Polak, K., Luksch, A., Frank, B., Jandrasits, K., Polska, E., Schmetterer, L., Regulation of human retinal blood flow by endothelin-1. Exp Eye Res 76 (2003), 633–640.
23. Ruggeri, M., Wehbe, H., Jiao, S., Gregori, G., Jockovich, M.E., Hackam, A., et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 48 (2007), 1808–1814.
24. Schmidt, K.G., Pillunat, L.E., Kohler, K., Flammer, J., Ocular pulse amplitude is reduced in patients with advanced retinitis pigmentosa. Br J Ophthalmol 85:6 (2001), 678–682.
25. Sigiyama, T., Moriya, S., Oku, H., Azuma, I., Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 39 (1997), S49–S56.
26. Simonson, M.S., Dunn, M.J., Cellular signaling by peptides of the endothelin gene family. FASEB J 4:12 (1990), 2989–3000.
27. Spaide, R.F., Koizumi, H., Pozzoni, M.C., Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146 (2008), 496–500.
28. Sutter, E.E., Tran, D., The field topography of ERG components in man — the photopic luminance response. Vis Res 32 (1992), 433–446.
29. Vingolo, E.M., Lupo, S., Grenga, P.L., Salvatore, S., Zinnamosca, L., Cotesta, D., et al. Endothelin-1 plasma concentrations in patients with retinitis pigmentosa. Regul Pept 160:1–3 (2010), 64–67.
30. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:6163 (1988), 411–415.
31. Yoshida, N., Ikeda, Y., Notomi, S., Ishikawa, K., Murakami, Y., Hisatomi, T., et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:1 (2013 Jan), e5–e12, 10.1016/j.ophtha.2012.07.008.
32. Yoshida, N., Ikeda, Y., Notomi, S., Ishikawa, K., Murakami, Y., Hisatomi, T., et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:1 (2013 Jan), 100–105, 10.1016/j.ophtha.2012.07.006.